Orexigen Therapeutic (OREX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OREX | AMGN | VRTX | REGN | GSK |
| Company | Orexigen Therapeutic | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.25 | 314.41 | 444.72 | 980.42 | 45.06 |
| High | 0.32 | 315.81 | 447.85 | 987.99 | 45.19 |
| Low | 0.22 | 312.62 | 442.98 | 978.21 | 44.40 |
| Last | 0.22 | 314.54 | 445.87 | 987.27 | 44.59 |
| Change | -0.12 | +2.07 | +0.66 | +4.98 | -0.39 |
| % Change | -34.41% | +0.66% | +0.15% | +0.51% | -0.87% |
| Volume | 3,735,400 | 1,394,700 | 742,200 | 317,800 | 5,172,400 |
| 20-Day Average Volume | 2,308,280 | 2,872,410 | 1,089,800 | 454,140 | 3,559,735 |
| Previous Close | 0.34 | 312.47 | 445.21 | 982.29 | 44.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.47 | 295.70 | 414.71 | 943.62 | 43.45 |
| 20-Day Raw Stochastic | 4.24% | 85.83% | 96.47% | 98.51% | 74.93% |
| 20-Day Relative Strength | 32.36% | 64.64% | 72.35% | 62.19% | 62.39% |
| Weighted Alpha | -72.99 | +42.40 | +36.13 | +35.48 | +33.02 |
| Today's Opinion | N/A | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | N/A | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | N/A | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.37% since 03/27/18 | +1.97% since 05/13/24 | +3.71% since 05/13/24 | +1.06% since 05/13/24 | -1.28% since 05/13/24 |
| Low | 0.17 on 03/28/18 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.40 on 05/20/24 |
| High | 0.39 on 04/02/18 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | -81.57% since 03/02/18 | +16.96% since 04/19/24 | +13.08% since 04/19/24 | +10.09% since 04/19/24 | +12.18% since 04/19/24 |
| Low | 0.17 on 03/27/18 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 1.42 on 03/09/18 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -82.02% since 01/03/18 | +10.94% since 02/20/24 | +6.00% since 02/20/24 | +4.27% since 02/20/24 | +6.12% since 02/20/24 |
| Low | 0.17 on 03/27/18 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 1.60 on 02/22/18 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -89.17% since 10/03/17 | +18.54% since 11/20/23 | +24.95% since 11/20/23 | +23.16% since 11/20/23 | +27.00% since 11/20/23 |
| Low | 0.17 on 03/27/18 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 2.32 on 10/13/17 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,212 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 18,890 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 33,710,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -24,520,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 18,900,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -20,830,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 2.46 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.35 on 11/13/17 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/08/18 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.89 | 29.26 | 26.08 | 11.11 |